Atlanta’s Dr. Veena Rao bestowed with 2022 Pink Frog Legacy Award

Veena N. Rao, PhD, professor and co-director of the Cancer Biology Program, at Morehouse School of Medicine, received the 2022 Pink Frog Legacy Award from the Pink Frog Foundation at its 10th Annual Pink Frog Affair at the Martin Luther King Jr. International Chapel, Morehouse College on Friday, October 14. The organization said it chose to honor Dr. Rao for her longstanding research on breast cancer. The anniversary celebration was a breast cancer awareness event and fundraiser which raised over $137,000 to support breast cancer patients in metro Atlanta.

Founded in 2012, the Pink Frog Foundation, Inc. is a registered 501c3 non-profit organization dedicated to providing support to breast cancer patients. In addition, the organization strives to provide emotional, social, and educational programming and to increase public awareness about the special needs and issues facing individuals with breast cancer.

Dr. Veena Rao, recipient of many coveted recognitions and awards is a Professor in the Department of Obstetrics and Gynecology at Morehouse School of Medicine and serves as co-director of the MSM Cancer Biology Program. She is also a Georgia Cancer Coalition Distinguished Cancer Scholar at Morehouse School of Medicine. Her research focuses on the BRCA1 gene and its role in breast and ovarian cancer in diverse populations, including triple-negative breast cancers (TNBC) that are more prevalent in African American women, are highly aggressive and have higher rates of metastasis.

On receiving the 2022 Pink Frog Legacy Award, Dr. Veena Rao said It was a memorable day I felt so good meeting the survivors they are an inspiration to all. Dr. Rao earned her PhD in Biochemistry from Osmania University, Hyderabad in India and completed part of her thesis work at Massachusetts Institute of Technology, Max Planck Institute, and University of Edinburgh. She completed fellowships in human genetics at Yale University School of Medicine and molecular biology at University of California, Berkeley, as well as being the Fogarty International Visiting Fellow studying Molecular Oncology at the National Cancer Institute. Dr. Rao received Bachelor of Science and Master of Science degrees from Osmania University.

She has obtained a patent for BRCA1 function-based assays, which can be used to stratify risk for TNBC in women who carry BRCA1 mutations and can also be used to develop targeted therapy for TNBC, a disease which currently has no mechanism-based precision treatments available. This technology when fully developed combined with BRCA1 genetic testing will revolutionize early detection for hereditary TNBC.

Not to mention, the countless lives it will save through early detection of these aggressive cancers, thus reducing the mortality in African American women, leading to health equity in line with MSM’s mission. Dr. Rao earned her PhD in Biochemistry from Osmania University in India and completed part of her thesis work at Massachusetts Institute of Technology, Max Planck Institute, and University of Edinburgh. She completed fellowships in human genetics at Yale University School of Medicine and molecular biology at the University of California, Berkeley, as well as being the Fogarty International Visiting Fellow studying Molecular Oncology at the National Cancer Institute. Dr. Rao received Bachelor of Science and Master of Science degrees from Osmania University.

Founded in 1975, Morehouse School of Medicine (MSM) is among the nation’s leading educators of primary care physicians, biomedical scientists, and public health professionals. An independent and private historically-Black medical school, MSM was recognized by the Annals of Internal Medicine as the nation’s number one medical school in fulfilling a social mission — the creation and advancement of health equity.